ResearcherShandong UniversityNo recent work listed
Jun Liu
Matched on ORCID iD 0000-0003-4707-7286; OpenAlex author ID A5100362128. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 24
2021: 1 paper · 2022: 2 papers · 2023: 2 papers
Papers 5
- Short-Term Outcomes Following Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial. Co-author DOI 10.1001/jamasurg.2023.5210↗
- Protein Induced by Vitamin K Absence II: A Potential Biomarker to Differentiate Pancreatic Ductal Adenocarcinoma from Pancreatic Benign Lesions and Predict Vas… Last author DOI 10.3390/jcm12082769↗
- Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer. Last author DOI 10.1007/s00432-022-03985-4↗
- Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre randomised controlled trial. Co-author DOI 10.1136/bmjopen-2021-057128↗
- Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Last author DOI 10.3389/fgene.2021.752025↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shutao Pan · 2 shared papers, 2022–2023 · strength 0.25
- Paper Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre… DOI 10.1136/bmjopen-2021-057128↗
- Paper Short-Term Outcomes Following Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Pancreatic Ductal Adenocarc… DOI 10.1001/jamasurg.2023.5210↗
- Xuemin Chen · 2 shared papers, 2022–2023 · strength 0.25
- Paper Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre… DOI 10.1136/bmjopen-2021-057128↗
- Paper Short-Term Outcomes Following Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Pancreatic Ductal Adenocarc… DOI 10.1001/jamasurg.2023.5210↗
- Jingdong Li · 2 shared papers, 2022–2023 · strength 0.25
- Paper Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre… DOI 10.1136/bmjopen-2021-057128↗
- Paper Short-Term Outcomes Following Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Pancreatic Ductal Adenocarc… DOI 10.1001/jamasurg.2023.5210↗
- Yahui Liu · 2 shared papers, 2022–2023 · strength 0.25
- Paper Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre… DOI 10.1136/bmjopen-2021-057128↗
- Paper Short-Term Outcomes Following Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Pancreatic Ductal Adenocarc… DOI 10.1001/jamasurg.2023.5210↗
- Xianjun Yu · 2 shared papers, 2022–2023 · strength 0.25
- Paper Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre… DOI 10.1136/bmjopen-2021-057128↗
- Paper Short-Term Outcomes Following Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Pancreatic Ductal Adenocarc… DOI 10.1001/jamasurg.2023.5210↗
- Yunfeng Cui · 1 shared paper, 2023 · strength 0.24
- Yang Yang · 1 shared paper, 2023 · strength 0.24
- Yu Zhang · 1 shared paper, 2023 · strength 0.24
- Yong Liu · 1 shared paper, 2022 · strength 0.20
- Yong Hong Liu · 1 shared paper, 2021 · strength 0.15
- Renyi Qin · 1 shared paper, 2022 · strength 0.13
- Min Wang · 1 shared paper, 2022 · strength 0.13
- Taoyuan Yin · 1 shared paper, 2022 · strength 0.13
- Zhenxiong Zhang · 1 shared paper, 2023 · strength 0.12
- Hongqin Ma · 1 shared paper, 2023 · strength 0.12
- Yichen Tang · 1 shared paper, 2023 · strength 0.12
- Min Wang · 1 shared paper, 2023 · strength 0.12
- Pei Lu · 1 shared paper, 2023 · strength 0.12
- Zheng Li · 1 shared paper, 2023 · strength 0.12
- Chen Liu · 1 shared paper, 2023 · strength 0.12
- Rong Liu · 1 shared paper, 2023 · strength 0.12
- Xiaowu Xu · 1 shared paper, 2023 · strength 0.12
- Renyi Qin · 1 shared paper, 2023 · strength 0.12
- Shunrong Ji · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.